Prenetics Global Limited Class A Ordinary Share
Compare this stock
PRE Stock Report Card
$
29%
Performance
Score:
10/100
PRE returned -86.81% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Technicals
Score:
36/100
PRE receives a 35 of 100 based on 14 indicators. 4 are bullish, 8 are bearish.
Earnings
Score:
44/100
PRE has missed earnings 2 times in the last 20 quarters.
Profit
Score:
13/100
Out of the last 10 quarters, PRE has had 2 profitable quarters and has increased their profits year over year on 1 of them.
Volatility
Score:
55/100
PRE has had a higher than average amount of volatility over the last 12 months giving it a score of 54 of 100.
Prenetics Global Limited Class A Ordinary Share Summary
Nasdaq / PRE
Healthcare
Medical - Diagnostics & Research
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
PRE scored poorly on our reportcard. Here are some similar companies and how they performed.
